Can Exercise Curb Cravings? Study Reveals How Work Out Impacts Appetite

Updated Feb 4, 2025 | 07:56 AM IST

SummaryObesity affects over one billion people worldwide, often driven by eating behaviors and hormonal imbalances. Exercise can help regulate appetite by influencing hunger-related hormones in the body.
Can Exercise Curb Cravings? Study Reveals How Work Out Impacts Appetite

The global obesity epidemic, affecting over one billion people worldwide, is largely driven by eating behaviors. Appetite, influenced by both intrinsic and environmental factors, plays a crucial role in weight management. A recent study how exercise affects appetite perception in obese males, shedding light on the physiological mechanisms behind hunger suppression post-exercise.

While exercise is well-known for its benefits in weight management, its direct impact on appetite control has remained a subject of debate. Appetite is regulated by a complex network of gastrointestinal and neurohormonal signals, including hormones like ghrelin, leptin, interleukin 6 (IL-6), and neuropeptide Y (NPY). These hormones influence hunger levels, satiety, and energy balance.

The study published in Physiological Reports examines investigated how moderate continuous aerobic exercise (MICE) alters these hormone levels in obese men, ultimately affecting their hunger perception. The findings reveal that certain myokines and cytokines shift dynamically post-exercise, potentially reducing appetite and offering a promising strategy for weight management.

Hormonal Responses to Exercise

The study found that after exercise, there was a significant increase in IL-6 and irisin levels in the exercise group compared to those who remained sedentary. These elevated concentrations persisted for an hour after working out. IL-6 has been associated with regulating metabolism and enhancing fat oxidation, while irisin plays a role in converting white fat into more metabolically active brown fat.

Conversely, the study reported a decrease in neuropeptide Y (NPY) levels, a key neurotransmitter responsible for stimulating appetite. The decline in NPY levels post-exercise suggests a temporary suppression of hunger, supporting the idea that exercise can curb cravings. However, the study did not observe significant changes in IL-7 or leptin levels, two other hormones involved in appetite regulation.

Why Some People Struggle to Lose Weight

Ghrelin, often called the “hunger hormone,” stimulates appetite by increasing activity in specific areas of the brain. Individuals with higher ghrelin levels generally find it harder to lose weight because their bodies signal hunger more frequently.

Research suggests that dieting can lead to an increase in ghrelin levels, making weight loss challenging. Certain medical conditions, such as Hashimoto’s thyroiditis, Prader-Willi syndrome, anorexia nervosa, and bulimia nervosa, are also linked to elevated ghrelin levels, complicating appetite regulation further.

Challenges in Implementing Exercise for Appetite Control

While exercise has clear benefits, the findings should be interpreted with caution. He pointed out that the study had a small sample size, making it difficult to draw definitive conclusions.

Moreover, he highlighted the challenges faced by obese individuals in maintaining an intensive exercise routine. While exercise-induced appetite suppression is promising, consistently engaging in high-intensity workouts may be unrealistic for those who struggle with mobility or fitness levels. More extensive studies are needed to determine the optimal exercise duration and intensity for effective appetite suppression.

Tips to Naturally And Safely Suppressing Appetite

Besides exercise, there are several strategies individuals can use to naturally suppress their appetite and improve satiety:

Increase Protein Intake: Protein-rich foods, such as lean meats, legumes, and dairy, promote feelings of fullness and reduce hunger.

Stay Hydrated: Drinking water before meals can help control portion sizes and prevent overeating.

Opt for Fiber-Rich Foods: Whole grains, vegetables, and fruits high in fiber take longer to digest, keeping you full for longer.

Reduce Simple Carbohydrates and Sugars: Simple carbs and sugars cause rapid spikes and crashes in blood sugar levels, leading to increased hunger.

Prioritize Sleep: Poor sleep disrupts hunger-regulating hormones, making it harder to control cravings.

Manage Stress: Chronic stress increases cortisol levels, which can lead to overeating and weight gain.

The study’s findings indicate that moderate exercise can temporarily suppress appetite by altering key hormones. While more research is needed to refine the details—such as optimal workout duration and intensity—this insight adds to the growing body of evidence supporting exercise as a tool for appetite regulation and weight management.

For individuals looking to curb cravings and maintain a healthy weight, incorporating a well-balanced diet alongside regular exercise remains the most sustainable approach. Future studies focusing on larger populations and long-term effects could provide deeper insights into how exercise can be optimized for appetite control, making it an effective strategy in combating obesity.

Exercise alone is not a magic solution for weight loss, but its impact on appetite hormones presents a promising avenue for managing hunger and energy balance. As research continues to evolve, it becomes increasingly clear that integrating physical activity with mindful eating habits can play a vital role in achieving and maintaining a healthy lifestyle.

End of Article

US Woman Runs 7 Marathons While Pregnant: How Can It Affect Mother And Baby?

Updated Nov 20, 2026 | 08:00 PM IST

Summary38-year-old Deirdre Keane completed seven World Marathon Majors while pregnant, including the New York City Marathon at 34 weeks. After receiving medical clearance, she continued running while monitoring her health. Marathon running may not be safe for all pregnant women. Medical clearance and individual assessment remain essential.
US Woman Runs 7 Marathons While Pregnant: How Can It Affect Mother And Baby?

Credit: AP Photos

A 38-year-old US nurse practitioner has completed seven marathons while pregnant with her first child, raising questions about the safety of intense exercise during pregnancy.

Deirdre Keane, who works at Memorial Sloan Kettering Cancer Center, had completed more than 60 marathons before taking on the World Marathon Majors.

She discovered she was pregnant after noticing a slower pace during the Tokyo Marathon in March. After receiving clearance from her obstetrician-gynaecologist (OB-GYN), she decided to continue racing.

US Woman Completes Seven Marathons While Pregnant

The World Marathon Majors include races in Tokyo, Boston, London, Sydney, Berlin, Chicago and New York.

Keane had initially signed up for 11 events, including seven major marathons, a trail marathon, two ultramarathons and an Ironman competition.

After discovering her pregnancy, she dropped the Ironman and one ultramarathon and agreed to take the Ireland marathon slowly.

She completed the New York City Marathon in just over four hours at 34 weeks of pregnancy, averaging 9 minutes and 26 seconds per mile, according to New York Road Runners. She had finished the same race in just over three hours in 2025.

"I knew how bizarre it was to be running a marathon at 34 weeks, but I also knew how fit I was and self-aware of my body at this point," Keane told The Associated Press.

Her doctor advised her to monitor her nutrition and hydration and stop exercising at the first sign of muscle cramping, according to the World Running Network.

"I want to teach my son resilience and that he can do hard things," she said.

Is It Safe To Run Marathons During Pregnancy?

Exercise is generally safe during an uncomplicated pregnancy. However, the intensity and type of activity matter.According to the American College of Obstetricians and Gynecologists (ACOG), women with healthy pregnancies can continue or begin regular physical activity after consulting their OB-GYN.

Women who regularly performed vigorous aerobic exercise before pregnancy may also be able to continue with medical approval.

However, research on prolonged, high-intensity activities such as marathon running during pregnancy remains limited.

ACOG recommends at least 150 minutes of moderate-intensity aerobic activity every week for pregnant women without medical or obstetric complications. Brisk walking and gardening are examples.

How Can Exercise Benefit The Mother And Baby?

Regular physical activity during pregnancy can:

  • Reduce back pain and constipation.
  • Lower the risk of gestational diabetes and preeclampsia.
  • Reduce the likelihood of a cesarean birth.

However, these benefits do not mean strenuous exercise is suitable for every pregnant woman. Consult an OB-GYN before starting or continuing an intense workout routine.

What Precautions Should Pregnant Women Take?

ACOG recommends the following precautions:

  • Stay hydrated: Drink water before, during, and after exercise. Dizziness, a racing heartbeat and dark yellow urine can indicate dehydration.
  • Avoid overheating: Wear loose-fitting clothes and exercise in a cool environment. Avoid workouts in extreme heat or humidity.
  • Use adequate support: Wear a supportive sports bra. A belly support belt may help later in pregnancy.
  • Avoid certain positions: Limit lying flat on your back or standing motionless for prolonged periods, as these can affect circulation and blood pressure.

Which Activities Should Pregnant Women Avoid?

Pregnant women should avoid activities that increase the risk of falls, abdominal injuries or overheating, including:

  • Contact sports such as boxing, ice hockey, soccer and basketball.
  • Horseback riding, downhill skiing, surfing and off-road cycling.
  • Skydiving and scuba diving.
  • Hot yoga and hot Pilates.
  • Exercising above 6,000 feet if they do not already live at high altitude.

Warning Signs To Watch Out For During Exercise

ACOG advises pregnant women to stop exercising and contact their OB-GYN if they experience:

  • Vaginal bleeding.
  • Dizziness or fainting.
  • Shortness of breath before exercising.
  • Chest pain or headache.
  • Muscle weakness.
  • Calf pain or swelling.
  • Regular, painful uterine contractions.
  • Fluid leaking or gushing from the vagina.

End of Article

How Keep The Weight Off After GLP-1 Treatment: Lancet Study Compares 5 Weight Maintenance Strategies

Updated Nov 16, 2026 | 08:00 PM IST

SummaryA recent study published in The Lancet's eClinicalMedicine compared five weight loss maintenance strategies after stopping or changing original GLP-1 treatment.
How Keep The Weight Off After GLP-1 Treatment: Lancet Study Compares 5 Weight Maintenance Strategies

Credit: AI-generated image

What happens when people stop taking GLP-1 weight-loss injections like Ozempic, Wegovy or Mounjaro? Do they regain weight, switch to another medication or consider bariatric surgery?

A new study published in The Lancet's eClinicalMedicine examined that what people do after their initial GLP-1 treatment can make a significant difference in their long-term weight outcomes.

Maintaining Weight After GLP-1 Treatment

Also read: World Diabetes Day: Why Some Diabetes Patients May Not Be Suitable For GLP-1 Treatment, Experts Explain

Researchers at Cleveland Clinic examined health records from 20,486 patients who had taken semaglutide or tirzepatide injections for at least three months.

They compared five weight loss maintenance over a two-year period: continuing the original weight loss medication, switching between the two drugs, moving to another obesity medication, undergoing bariatric surgery or stopping treatment altogether without pursuing another option.

After two years, the average weight reductions were:

  • Bariatric surgery: Approximately 28% of body weight.
  • Switching between semaglutide and tirzepatide: 16%.
  • Continuing the original GLP-1 medication: Nearly 11%.
  • Switching to another obesity medication: Approximately 8%.
  • Stopping treatment without further intervention: Approximately 4%.

These results indicate that discontinuing GLP-1 treatment does not mean all the lost weight will come back. But patients who stopped treatment without another medical or surgical intervention experienced the lowest success in keeping the weight off.

The study also found that the outcomes of switching depended on which medication patients were taking initially. Those who moved from semaglutide to tirzepatide lost more weight than those who continued semaglutide. However, among people initially taking tirzepatide, remaining on the medication led to greater weight loss than switching to semaglutide.

What Happens To Blood Sugar And Blood Pressure After Stopping?

Also read: Stopping Ozempic or Wegovy May Double Your Risk Of Heart Attack, Death

Not just weight loss, the findings also covered metabolic outcomes as patients with existing health conditions also showed significant differences.

Among participants with type 2 diabetes, bariatric surgery proved to drive major improvement in HbA1c. This was followed by switching between semaglutide and tirzepatide, continuing the original medication and moving to another obesity drug.

Patients with hypertension who continued treatment also experienced greater reductions in blood pressure than those who stopped.

Those who discontinued treatment without another intervention showed the smallest improvements in blood glucose control and blood pressure.

Why Do People Stop Taking Weight-Loss Injections?

GLP-1 medications have become increasingly popular for managing diabetes and combating obesity, but long-term treatment can be difficult for some patients to maintain.

Cost, insurance and side effects are among the reasons why people may discontinue these medicines. Gastrointestinal symptoms like nausea, vomiting, diarrhoea and constipation can also affect adherence to treatment.

People who cannot continue their original medication, and are considering switching to another treatment or considering bariatric surgery should discuss their options with their healthcare providers.

Lead author Hamlet Gasoyan, a researcher at Cleveland Clinic's Center for Value-Based Care Research, said, “The encouraging news is that, for patients who need to stop their injectable GLP-1 medication, it does not mean that their obesity treatment journey has to end.”

Co-author Ali Aminian, director of Cleveland Clinic's Bariatric and Metabolic Institute, added, “When a patient stops a GLP-1 medication, the most important question is what comes next.”

He noted that patients who stopped all treatment had the least weight loss while those who moved on to another therapy, particularly bariatric surgery, did significantly better.

End of Article

Not Everyone With Obesity Is Unhealthy: New Study Challenges BMI

Updated Nov 12, 2026 | 07:17 AM IST

SummaryA recent study found that body mass index (BMI) could inaccurately diagnose people with obesity. It suggested that overweight people should be classified into two categories: pre-clinical obesity and clinical obesity.
Not Everyone With Obesity Is Unhealthy: New Study Challenges BMI

Credit: iStock

For years, body mass index (BMI) has been a key health marker to track obesity. But a recent study suggests that not everyone classified as obese based on their BMI may have obesity-related health problems. Researchers say just considering BMI alone may lead to incorrect diagnosis in some people while overlooking others with excess body fat and related health risks.

The international study, involving more than 844,000 adults across China, the UK, the US and Spain, supports a different approach that considers body fat distribution, waist measurement and the impact of excess fat on organ function.

Researchers propose distinguishing between two categories: pre-clinical obesity, in which excess body fat increases health risks but has not impaired organ function, and clinical obesity, in which excess fat is already affecting the body's ability to function.

BMI Alone Not Enough To Diagnose Obesity

Also read: Why WHO Wants To Use Smartwatches To Track Physical Activity & Sedentary Behaviour At A Population Level?

BMI is calculated by dividing a person's weight in kilograms by their height in metres squared. It is used to classify people as underweight, normal weight, overweight or obese.

However, BMI does not directly measure body fat or show where fat is distributed. It also cannot distinguish between fat and muscle mass. Consequently, two people with the same BMI may have very different body compositions and health risks.

The researchers found that adding waist circumference and waist-to-height ratio to BMI helped identify people whose excess body fat might otherwise be missed.

The analysis suggested that BMI alone missed obesity level body fat in up to 8.6% of participants, while incorrectly classifying up to 3.1% as having obesity in the study groups.

Professor Francesco Rubino, senior author of the study and Chair of Metabolic and Bariatric Surgery at King's College London, said, “Body mass index alone cannot tell us whether someone is already ill or at risk of illness, or what care they need, leaving people vulnerable to both undertreatment and overtreatment.”

Difference Between Clinical And Pre-Clinical Obesity

Also read: Loud Snoring Is Not Always Harmless: Sleep Apnoea can Become a Stroke-Risk Concern

The researchers used a framework proposed by the Lancet Diabetes and Endocrinology Commission in 2025. It separates obesity into two categories based on whether excess body fat has affected a person's health.

  • Pre-clinical obesity: A person has excess body fat that increases their risk of developing health problems, but their organ function and everyday activities remain unaffected.
  • Clinical obesity: Excess body fat has impaired organ function or affected a person's ability to perform daily activities. It is considered an active disease that requires clinical assessment.

The study estimated that only around 23% to 31% of people classified as having obesity across the four study populations had clinical obesity. This represented approximately 5.6% to 10.9% of the overall adult populations studied.

When Do People With Pre-Clinical Obesity Develop Health Problems?

The researchers followed participants over time to examine how often pre-clinical obesity progressed to clinical obesity.

They found that approximately 77% to 91% of people classified as having pre-clinical obesity did not progress to clinical obesity over 10 years. However, progression rates differed across the study populations.

Clinical obesity was linked with a higher risk of death while pre-clinical obesity had a more modest increase in risk.

Professor Rubino said, “Preclinical obesity should therefore be neither treated automatically as active disease nor dismissed as harmless. Some people may need preventive treatment, but its intensity should match their individual risk.”

The findings do not mean that people with pre-clinical obesity should ignore excess body fat. Rather, they highlight the importance of assessing individual health risks instead of making treatment decisions based on BMI alone.

People with excess body fat may still benefit from lifestyle hanges, treatment and preventive care even if they have not developed organ dysfunction.

End of Article